Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-096102

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Graeme Bell
Officer — Executive VP and CFO
Period of report
Feb 3, 2016
Accepted (ET)
Feb 5, 2016 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 3, 2016A5,000$0.00A11,006D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2$78.91Feb 3, 2016A25,299A—Feb 3, 2026Common Stock25,29925,299D
Performance Restricted Stock UnitsF3—Feb 3, 2016A5,000A——Common Stock5,0005,000D

Explanation of responses